Healthcare >> Analyst Interviews >> March 3, 2003

Outlook For Major Pharmaceuticals: Girish Tyagi – Thomas Weisel Partners

DR. GIRISH TYAGI is a Principal in the Research Department at Thomas Weisel Partners LLC, where he covers the Major Pharmaceuticals sector. Previously, he was the Senior Healthcare Analyst at ABN Amro. Prior to entering the securities business, Dr. Tyagi practiced medicine for 15 years. Dr. Tyagi received a Pre-Medical degree from Delhi University, a Medical degree from the M.A. Medical College of New Delhi, India, and a Master of Business Administration degree from Northeastern University in Boston, Massachusetts. Dr. Tyagi is board certified in Internal Medicine (United Kingdom) and Radiology (United States and United Kingdom). He is a Member of the Royal College of Physicians of the United Kingdom and a Fellow of the Royal College of Radiologists. Profile
TWST: Let's start out with a review of what's happened to the

large cap pharmaceuticals this past year, and what your current

approach is for that sector.

Dr. Tyagi: Both 2001 and 2002 were